Loading clinical trials...
Loading clinical trials...
A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
Conditions
Interventions
MARS
Standard Medical Therapy
Locations
8
United States
University of Alabama
Birmingham, Alabama, United States
University of California, San Diego
San Diego, California, United States
Northwestern University
Chicago, Illinois, United States
University of Michigan
Ann Arbor, Michigan, United States
Columbia-Presbyterian Medical Center
New York, New York, United States
University of Virginia
Charlottesville, Virginia, United States
Start Date
September 1, 2000
Primary Completion Date
November 1, 2003
Completion Date
April 1, 2004
Last Updated
March 3, 2025
NCT07329036
NCT06831643
NCT07275554
NCT06483737
NCT06948565
NCT06340269
Lead Sponsor
Vantive Health LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions